DK2556833T3 - Farmaceutisk sammensætning til behandling af alzheimers sygdom, fremgangsmåde til fremstilling og anvendelse deraf - Google Patents

Farmaceutisk sammensætning til behandling af alzheimers sygdom, fremgangsmåde til fremstilling og anvendelse deraf

Info

Publication number
DK2556833T3
DK2556833T3 DK11764967.3T DK11764967T DK2556833T3 DK 2556833 T3 DK2556833 T3 DK 2556833T3 DK 11764967 T DK11764967 T DK 11764967T DK 2556833 T3 DK2556833 T3 DK 2556833T3
Authority
DK
Denmark
Prior art keywords
disease
preparing
procedure
pharmaceutical composition
treating alzheimer
Prior art date
Application number
DK11764967.3T
Other languages
English (en)
Inventor
Sousa Buck Hudson De
Nunes Marielza Andrade
Original Assignee
Fundação Arnaldo Vieira De Carvalho
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundação Arnaldo Vieira De Carvalho filed Critical Fundação Arnaldo Vieira De Carvalho
Application granted granted Critical
Publication of DK2556833T3 publication Critical patent/DK2556833T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK11764967.3T 2010-04-07 2011-04-07 Farmaceutisk sammensætning til behandling af alzheimers sygdom, fremgangsmåde til fremstilling og anvendelse deraf DK2556833T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI1000970-1A BRPI1000970A2 (pt) 2010-04-07 2010-04-07 composição farmacêutica para o tratamento da doença de alzheimer, processo para sua obtenção e uso
PCT/BR2011/000097 WO2011123916A1 (pt) 2010-04-07 2011-04-07 Composição farmacêutica para o tratamento da doença de alzheimer, processo para sua obtenção e uso

Publications (1)

Publication Number Publication Date
DK2556833T3 true DK2556833T3 (da) 2017-11-06

Family

ID=44761943

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11764967.3T DK2556833T3 (da) 2010-04-07 2011-04-07 Farmaceutisk sammensætning til behandling af alzheimers sygdom, fremgangsmåde til fremstilling og anvendelse deraf

Country Status (6)

Country Link
US (1) US20130156869A1 (da)
EP (1) EP2556833B1 (da)
CN (1) CN102858349A (da)
BR (1) BRPI1000970A2 (da)
DK (1) DK2556833T3 (da)
WO (1) WO2011123916A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9603869B2 (en) 2015-05-22 2017-03-28 University Of South Florida Lithium co-crystals and an additional neuropsychiatric agent for treatment of neuropsychiatric disorders
CN105920034A (zh) * 2016-05-30 2016-09-07 宁波大学 氯化锂在制备甲基苯丙胺认知障碍药物中的应用
WO2019241376A1 (en) 2018-06-14 2019-12-19 The Trustees Of Columbia University In The City Of New York Treatment of cognitive disorders using nitazoxanide (ntz), nitazoxanide (ntz) analogs, and metabolites thereof
US20230085573A1 (en) * 2020-02-01 2023-03-16 Ageless Sciences, Inc. Compositions and Methods for Treating Aging-Related Disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8601915D0 (en) 1986-01-27 1986-03-05 Efamol Ltd Pharmaceutical compositions
EP0289204B1 (en) * 1987-04-27 1991-07-17 Efamol Holdings Plc Lithium salt-containing pharmaceutical compositions
AU1067795A (en) 1993-11-26 1995-06-13 Karla Lehmann Use of lithium compounds in the treatment and prevention of alzheimer's disease
US6160018A (en) * 1995-03-13 2000-12-12 Loma Linda University Medical Center Prophylactic composition and method for alzheimer's Disease
US7378111B2 (en) * 2002-02-20 2008-05-27 The Trustees Of The University Of Pennsylvania Regulation of GSK-3α activity for the treatment or prevention of Alzheimer's disease
WO2004107881A1 (en) * 2003-06-04 2004-12-16 Serfontein, Willem, Jacob Nutritional compositions and use thereof
EP1652512A1 (en) * 2004-11-02 2006-05-03 Medesis Pharma Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation
MX2008006037A (es) 2005-11-10 2009-03-03 Circ Pharma Res And Dev Ltd Drogas para el sistema nervioso central para administracion una-vez-al-dia.
WO2010098888A1 (en) * 2009-02-27 2010-09-02 Massachusetts Institute Of Technology Uses of chemicals to modulate gsk-3 signaling for treatment of bipolar disorder and other brain disorders
WO2012007387A1 (en) * 2010-07-13 2012-01-19 Medesis Pharma Low- dose lithium for the treatment of neurodegenerative disorders

Also Published As

Publication number Publication date
CN102858349A (zh) 2013-01-02
EP2556833B1 (en) 2017-07-26
WO2011123916A1 (pt) 2011-10-13
EP2556833A1 (en) 2013-02-13
US20130156869A1 (en) 2013-06-20
EP2556833A4 (en) 2013-09-04
BRPI1000970A2 (pt) 2011-11-29

Similar Documents

Publication Publication Date Title
DK3081568T3 (da) Sammensætninger og fremgangsmåder til behandling af alzheimers sygdom
DK3444261T3 (da) 2,2-difluorpropionamidderivat af bardoxolonmethyl, farmaceutiske sammensætninger og polymorfer deraf til anvendelse ved behandling af visse lidelser
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
HUE036780T2 (hu) Új kompozíciók és eljárások immunológiai vonatkozású betegségek kezelésére
IL247741B (en) Pharmaceutical compositions comprising iron oxy-hydroxide, methods for the preparation thereof and their uses
DK2632954T4 (da) Midler og fremgangsmåder til behandling af dlbcl
DK2324126T3 (da) FREMGANGSMÅDE TIL IDENTIFICERING AF Alzheimers SYGDOMSRISIKOFAKTORER
DK3434687T3 (da) Hidtil ukendte oxyntomodulinderivater og farmaceutisk præparat til behandling af fedme omfattende samme
DK2726511T3 (da) Sammensætninger, anvendelser og fremgangsmåder til behandling af stofskiftesygdomme og -lidelser
DK2410981T4 (da) Tørpulverformuleringer og fremgangsmåder til behandling af lungesygdomme
PL2892563T3 (pl) Kompozycje farmaceutyczne do leczenia choroby alzheimera
DK3196309T3 (da) Thraustochytrider, fedtsyresammensætninger og fremgangsmåder til fremstilling og anvendelse deraf
HUE049880T2 (hu) Anyag és eljárások Her-3-mal összefüggõ betegségek kezelésére vagy megelõzésére
DK2432798T3 (da) 17-hydroxy-17-pentaflourethyl-estra-4,9(10)-dien-11-aryl-derivat, fremgangsmåde til fremstilling heraf og anvendelse heraf til behandling af sygdomme
DK2303330T4 (da) Farmaceutiske sammensætninger til behandling af parkinsons sygdom
DK2699553T3 (da) Substituerede diaminocarboxamid- og diaminocarbonitrilpyrimidiner, sammensætninger deraf og fremgangsmåder til behandling dermed
IL225597A0 (en) Pharmaceutical preparation, methods of treatment and its uses
HUE036537T2 (hu) ECM kompozíció, tumor-mikrokörnyezet platform és ezekhez eljárások
DK2276485T3 (da) Anvendelse af epothilon d i behandling af tau-associerede sygdomme,herunder alzheimers sygdom
HUE037105T2 (hu) Eljárások és készítmények tumorok megsemmisítésére
DK2340042T3 (da) Fremgangsmåder og præparater til behandling af cancer
DK2182960T3 (da) Forbindelser, formuleringer og fremgangsmåder til reducering af hudrynker, furer og slaphed
BRPI0921507A2 (pt) composição, método de preparação de um excipiente, comprimido farmacêutico e método de preparação do mesmo
DK3479863T3 (da) Sammensætninger, fremgangsmåder og artikler indeholdende farmaceutisk nitrogenoxid og regulerede leveringssystemer deraf til patienter
DK2557924T3 (da) Dermale farmaceutiske sammensætninger af 1-methyl-2',6'-pipecoloxylidid og fremgangsmåde til deres anvendelse